← Human Trials & Peer-Reviewed Studies
Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States
Plain-language guide to PMID 21289257 (2011): clinical trial study of Vasopressin in 20 volunteers.
Key Facts
- PMID
- 21289257
- Journal
- The Journal of clinical endocrinology and metabolism
- Year
- 2011
- Study type
- Clinical Trial
- Authors
- Balanescu S et al. (6 authors)
- DOI
- 10.1210/jc.2010-2499
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vasopressin, published as a clinical trial.
To correlate plasma copeptin with plasma osmolality and vasopressin concentrations in healthy subjects during iso-, hypo-, and hyperosmolar states.
Why It Was Studied
Copeptin, the C-terminal moiety of provasopressin, is cosecreted with vasopressin.
Copeptin may be a useful parameter to characterize disorders of water homeostasis and can be readily measured in plasma or serum.
Who Took Part
The abstract describes 20 volunteers taking part.
By PubMed's age tags, the people studied were young adults and adults, both men and women.
How the Study Was Run
Correlation coefficients were determined between plasma osmolalites and copeptin and vasopressin concentrations, as well as between vasopressin and copeptin concentrations.
What Was Measured
Copeptin may be a useful parameter to characterize disorders of water homeostasis and can be readily measured in plasma or serum.
However, it is unknown to date how circulating copeptin and vasopressin levels correlate at different plasma osmolalites.
PubMed files the paper under topics including Glycopeptides, Health Status, Hypotonic Solutions, Osmolar Concentration, Saline Solution, Hypertonic, Vasopressins and Water.
What This Means in Plain Language
This is a clinical trial of Vasopressin in 20 volunteers.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2011 (The Journal of clinical endocrinology and metabolism), a journal based in United States.
More context: the Vasopressin compound page, all human trials.
Our Notes on the Compound
Vasopressin: A 9-amino-acid hormone (antidiuretic hormone) that controls water balance and blood vessel tone; used in septic shock.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.